Bharat Biotech, SII arm Bilthoven Biologicals be a part of fingers for international polio eradication

Table of Contents

what is DMA (Direct Market Access)in the Indian share market?

What is DMA?

DMA, or Direct Market Access, is a service offered by stockbrokers that allows traders to place orders directly on the stock exchange’s order book. It eliminates the need for intermediaries, such as market makers or brokers, and provides traders with direct access to the market. This means that orders are executed faster and at potentially better prices.

How Does DMA Work in the Indian Share Market?

In the Indian share market, DMA is facilitated through the use of technology and trading platforms provided by stockbrokers. Traders can access the market through these platforms, which connect them directly to the stock exchange.

Benefits of DMA in the Indian Share Market

1. Speed and Efficiency: DMA enables faster order execution as orders are placed directly on the exchange’s order book. This can be particularly advantageous in volatile market conditions where every second counts.


DMA, or Direct Market Access, is a powerful tool that allows traders to directly access the stock exchange’s order book. In the Indian share market, DMA offers numerous benefits, including speed, transparency, control, lower costs, and access to real-time market data. By utilizing DMA, traders can enhance their trading experience and potentially improve their trading outcomes.

HYDERABAD: Vaccine maker Bharat Biotech has joined fingers with Serum Institute of India’s (SII) wholly-owned Dutch subsidiary Bilthoven Biologicals BV (BBio) for the procurement of drug substances for the manufacturing of oral polio vaccines for the Indian in addition to international markets.Bharat Biotech and Bilthoven Biologicals, who’ve entered into an settlement, will collectively get hold of the regulatory approvals and licenses required to commercially manufacture OPVs in India for international provides from drug substances manufactured within the Netherlands at Bilthoven Biologicals, a joint assertion by Bharat Biotech and SII mentioned.Commenting on the event, SII CEO Adar Poonawalla mentioned “We are delighted to join forces with Bharat Biotech to reinforce the global supply of polio vaccines. Our vision is to eradicate polio worldwide, taking a crucial step towards reducing the impact of this deadly disease on vulnerable populations.”Bharat Biotech govt chairman Dr Krishna Ella mentioned, “This collaboration between BBIL and BBio exemplifies cooperation between vaccine companies, ensuring a secure supply of oral polio vaccines and fortifies the nation’s mission to eradicate polio.”“Oral polio vaccines have been an integral part of the government of India’s universal immunisation programme (UIP) for several decades, with Bharat Biotech being one of the largest suppliers to immunisation programmes across the world,” Dr Ella added.The 2 gamers mentioned because the world approaches the important part of worldwide polio eradication, this collaboration will help the hassle to create a polio-free world.

#Bharat #Biotech #SII #arm #Bilthoven #Biologicals #be a part of #fingers #international #polio #eradication

Leave a Reply